Eidos治疗(EIDX)

122.21 0.00 0.0%

今开:0.0昨收:122.21
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:4.74931561E9

Eidos治疗的热门评论

IPO公司简析-Eidos Therapeutics

淘沙见金2018-08-19 12:37

(原文发表地址: 网页链接,本文在原文的基础上有更新)Eidos Therapeutics ($Eidos Therapeutics(EIDX)$ )是一家临床阶段的生物制药公司,专注于解决由转甲状腺素蛋白(transthyretin,TTR)淀粉样变性(amyloidosis,ATTR)引发的疾病。公司新股的发行价15.00-17.00...查看全文

淘沙见金2018-08-28 20:05

$Eidos Therapeutics(EIDX)$ $辉瑞(PFE)$ 对数据分析的比较详细[牛][牛][牛]查看全文

淘沙见金2018-08-27 22:45

$Eidos Therapeutics, Inc.(EIDX)$ The data seem almost a worse case for EIDX (will be interesting to see their management spin). $辉瑞(PFE)$ had good efficacy and so set the bar high for a drug with a similar MOA. In addition, the lack of a dose response undermines the EIDX ar...查看全文

Eidos治疗(EIDX)2019-07-09 22:55

$Eidos治疗(EIDX)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-07-09 AccNo: 0001193125-19-190741 Size: 34 KB 网页链接查看全文

淘沙见金2018-06-20 10:26

$Eidos Therapeutics(EIDX)$ 明天要IPO的一家公司。主要研发产品AG10跟辉瑞的tafamidis原理很像,都是口服给药的小分子TTR stabilizers。原理都是通过选择性稳定四聚体TTR,从而在一开始就停止ATTR的产生一系列分子事件。ATTR这个罕见病多个巨头竞争,这以后要是临床成功了Patisiran/Inotersen 压...查看全文

Eidos治疗(EIDX)2019-06-18 12:05

$Eidos治疗(EIDX)$ 8-K - Current report Filed: 2019-06-17 AccNo: 0001193125-19-174717 Size: 28 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission of...查看全文

Eidos治疗(EIDX)2019-05-30 22:00

$Eidos治疗(EIDX)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-05-30 AccNo: 0001193125-19-159860 Size: 35 KB 网页链接查看全文

Eidos治疗(EIDX)2019-05-08 09:35

$Eidos治疗(EIDX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-07 AccNo: 0001564590-19-016564 Size: 6 MB 网页链接查看全文

Eidos治疗(EIDX)2019-05-08 09:35

$Eidos治疗(EIDX)$ 8-K - Current report Filed: 2019-05-07 AccNo: 0001564590-19-016554 Size: 323 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Eidos治疗的最新评论

Eidos治疗(EIDX)2021-01-27 05:27

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017733 Size: 29 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-003286 Size: 7 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-21-017696 Act: 33 Size: 22 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017697 Act: 33 Size: 23 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017698 Act: 33 Size: 23 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017699 Act: 33 Size: 23 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-26 22:06

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017128 Act: 34 Size: 33 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-26 21:51

$Eidos治疗(EIDX)$ 8-K Current report, items 1.01, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-21-017109 Act: 34 Size: 381 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-26 21:51

$Eidos治疗(EIDX)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-000105 Act: 34 Size: 2 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-21 05:27

$Eidos治疗(EIDX)$ 8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001193125-21-012447 Act: 34 Size: 208 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Eidos治疗的公告

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017733 Size: 29 KB 网页链接

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-003286 Size: 7 KB 网页链接

$Eidos治疗(EIDX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-21-017696 Act: 33 Size: 22 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017697 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017698 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017699 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017128 Act: 34 Size: 33 KB 网页链接

$Eidos治疗(EIDX)$ 8-K Current report, items 1.01, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-21-017109 Act: 34 Size: 381 KB 网页链接

$Eidos治疗(EIDX)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-000105 Act: 34 Size: 2 KB 网页链接

$Eidos治疗(EIDX)$ 8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001193125-21-012447 Act: 34 Size: 208 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15